Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,551 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 388
Recruiting: 216
Ph III recruiting: 36
Growth YoY: +7.4%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 30.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 251–300 of 1,551 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05515796	Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors	completed	Phase 2	189	Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER	1	Apr 1, 2026	clinicaltrials
NCT07505472	Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria(STARS-RC10)	recruiting	Phase 2 / Phase 3	212	The First Hospital of Jilin University